Testosterone Administration Modulates Competitive Choice via Ventral Striatum and TPJ

How does testosterone influence decisions and choice-related neural computations in competitive environments? To address this question, we administered testosterone or placebo to female participants (n = 54) in a double-blind, randomized design. Following drug treatment, participants competed in a dot estimation task that manipulated opponent status (lower, equal, or higher) and outcome feedback (win or loss), after which they decided whether to compete against the same opponent again. All participants adjusted their behavior based on opponent status and outcome feedback. Participants who received testosterone, however, showed significantly greater sensitivity to outcome feedback: they were more willing to compete after winning and less willing after losing, and made those decisions faster - suggesting that testosterone increases the weighting of immediate, salient outcome information in competitive decision-making. At the neural level, a network comprising ventral striatum, vmPFC, bilateral TPJ and ACC processed outcome-related signals during the feedback period. Critically, neural prediction analyses at the trial-level revealed that activity in left ventral striatum and TPJ predicted subsequent decisions to compete, but only in participants who received testosterone. The direction of these effects mirrored the behavioral results: striatal activity amplified the tendency to re-compete after winning, whereas TPJ activity predicted renewed competition after losing. Together, these findings demonstrate that testosterone biases competitive decisions by amplifying the influence of outcome-related activity in reward and social cognition circuits.